Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis

被引:27
|
作者
Wang, Long
Li, Mian
Zhao, Zhiyun
Xu, Min
Lu, Jieli
Wang, Tiange
Chen, Yuhong
Wang, Shuangyuan
Dai, Meng
Hou, Yanan
Wu, Xueyan
Ma, Lina
Li, Lin
Liu, Shanshan
Wang, Weiqing
Xu, Yu
Bi, Yufang
Ning, Guang
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Endocrine & Metab Dis, Natl Clin Res Ctr Metab Dis,Rui Jin Hosp, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Endocrine & Metab Dis, Shanghai, Peoples R China
来源
AMERICAN JOURNAL OF MEDICINE | 2018年 / 131卷 / 12期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Cardiovascular health; Cohori; Nonalcoholic fatty liver disease; Prevention; FIBROSIS SCORE; NAFLD; RISK; PREVALENCE; MORTALITY; PREDICTOR;
D O I
10.1016/j.amjmed.2018.07.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Cardiovascular health has been proven to be associated with major cardiometabolic diseases. However, little is known of associations between cardiovascular health and nonalcoholic fatty liver disease. METHODS: This study included 3424 adults aged >= 40 years who were free of nonalcoholic fatty liver disease at baseline from a community cohort followed for up to 5 years. Liver ultrasonography was conducted at baseline and at follow-up to diagnose incident nonalcoholic fatty liver disease. Six metrics including smoking, physical activity, body mass index, total cholesterol, blood pressure, and fasting glucose were used to define cardiovascular health status. Associations of individual cardiovascular health metrics, number of cardiovascular health metrics, and overall cardiovascular health status at baseline, as well as changes in cardiovascular health during follow-up with risks of developing nonalcoholic fatty liver disease, were examined. RESULTS: A total of 649 participants developed nonalcoholic fatty liver disease during follow-up. Risks of nonalcoholic fatty liver disease reduced in a dose response manner in participants with 3-4 ideal cardiovascular health metrics (odds ratio 0.50; 95% confidence interval, 0.41-0.61) and in participants with 5-6 ideal metrics (odds ratio 0.34; 95% confidence interval 0.22-0.51) compared with participants with 0-2 ideal metrics. An overall ideal or intermediate cardiovascular health was associated with 37% reduction in developing nonalcoholic fatty liver disease compared with poor cardiovascular health. In addition, improving cardiovascular health during follow-up reduced the risk by 71% compared with deteriorating cardiovascular health. Furthermore, an overall ideal or intermediate cardiovascular health was significantly associated with a lower fibrosis score in nonalcoholic fatty liver disease patients compared with an overall poor cardiovascular health. CONCLUSIONS: Ideal cardiovascular health was inversely associated with risks of nonalcoholic fatty liver disease. Although treatment of nonalcoholic fatty liver disease and subsequent inflammation and fibrosis remains a challenge, cardiovascular health goals should be advocated for nonalcoholic fatty liver disease prevention. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:1515.e1 / 1515.e10
页数:10
相关论文
共 50 条
  • [31] Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease
    Du, Jing
    Pan, Xiaoping
    Lu, Zhigang
    Gao, Meifang
    Hu, Xiang
    Zhang, Xueli
    Bao, Yuqian
    Jia, Weiping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S138 - S138
  • [32] Nonalcoholic Fatty Liver Disease is Associated With Erectile Dysfunction: A Prospective Pilot Study
    Duman, Deniz Guney
    Bicakci, Ercan
    Celikel, Cigdem Ataizi
    Akbal, Cem
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (03): : 383 - 388
  • [33] Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?
    Softic, Samir
    Kahn, C. Ronald
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 143 - 143
  • [34] Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation
    Tilg, Herbert
    Moschen, Alexander
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04): : 391 - 396
  • [35] Ideal cardiovascular health associated with fatty liver: Results from a multiethnic survey
    Mazidi, Mohsen
    Katsiki, Niki
    Mikhailidis, Dimitri P.
    Banach, Maciej
    ATHEROSCLEROSIS, 2019, 284 : 129 - 135
  • [36] CARDIOVASCULAR RISK FACTORS IN NONALCOHOLIC FATTY LIVER DISEASE/NONALCOHOLIC STEATOHEPATITIS
    Ivanova, R.
    Gospodinova, M.
    Petrova, J.
    Alexiev, A.
    Denchev, S.
    Mateva, L.
    ATHEROSCLEROSIS, 2014, 235 (02) : E240 - E240
  • [37] Serum Vitamin D is Inversely Associated with Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in the General Population
    Kim, Donghee
    Kim, Won
    Kim, Hwa Jung
    HEPATOLOGY, 2013, 58 : 514A - 514A
  • [38] Nonalcoholic fatty liver disease and its association with cardiovascular disease
    Lizardi-Cervera, Javier
    Aguilar-Zapata, Daniel
    ANNALS OF HEPATOLOGY, 2009, 8 : S40 - S43
  • [39] Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms
    Moller, Soren
    Kimer, Nina
    Kronborg, Thit
    Grandt, Josephine
    Hove, Jens Dahlgaard
    Barlose, Mads
    Gluud, Lise Lotte
    SEMINARS IN LIVER DISEASE, 2021, 41 (03) : 235 - 247
  • [40] Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
    Hamaguchi, Masahide
    Kojima, Takao
    Takeda, Noriyuki
    Nagata, Chisato
    Takeda, Jun
    Sarui, Hiroshi
    Kawahito, Yutaka
    Yoshida, Naohisa
    Suetsugu, Atsushi
    Kato, Takahiro
    Okuda, Junichi
    Ida, Kazunori
    Yoshikawa, Toshikazu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (10) : 1579 - 1584